Article Text

Download PDFPDF

P178 5 year follow up of patients investigated for suspected pe. what further tests for suspected vte are performed and are they positive?
Free
  1. J Henderson1,
  2. S Hainey1,
  3. M Avery1,
  4. NCD Morley2,
  5. KC Muir2,
  6. EJR van Beek2,
  7. JT Murchison2
  1. 1University of Edinburgh, Edinburgh, UK
  2. 2Clinical Research Imaging Centre, Edinburgh, UK

Abstract

The diagnosis of a Pulmonary Embolism (PE) is a challenging clinical problem, our approach to which has changed greatly since the introduction of Computed tomographic pulmonary angiography (CTPA). CTPA is now established as the imaging modality of choice for the diagnosis of PE, however there are concerns that CTPA causes the over-diagnosis of clinically irrelevant PE,1,2 and there is little data concerning the outcomes and further imaging following a CTPA at long follow-up times. Here we present long term follow-up of CTPAs over 5 years, looking at further imaging related to suspected thromboembolic disease after more than 2000 studies. After their initial CTPA, further studies were documented retrospectively using electronic patient records. Figure 1 demonstrates what further imaging for suspected venous thromboembolic event (VTE) patients had following their CTPAs scans over 5 years. In a one-year period, 24% of the negative studies, 38% of the positive, and 50% of the indeterminate studies had repeat testing for suspected thromboembolic disease. Indeterminate studies received repeat testing faster (p<0.001), and those with negative studies received fewer repeat tests (p<0. 001). Those with a positive initial result were more likely to have positive recurrent testing over the whole 5 year period, and these data also suggest a trend showing increased risk with positive PEs rather than other VTEs. Furthermore, although CTPAs had a very high calculated negative predictive value for excluding PE (over 99%), many patients went on to have repeat testing following a negative result. Understanding how test Results influence the predictive value of further testing is essential for effective risk stratification, and this work adds to the growing body of data examining the long-term implications of a CTPA result.

References

  1. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis. Arch Intern Med. American Medical Association2011;171(9):831–7.

  2. Morley NCD, Muir KC, Mirsadraee S, van Beek EJR, Murchison JT. Ten years of imaging for pulmonary embolism: Too many scans or the tip of an iceberg?Clin Radiol: Elsevier2015.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.